BOTOX - 0023-1145-02 - (onabotulinumtoxinA)

Alphabetical Index


Drug Information of BOTOX

Product NDC: 0023-1145
Proprietary Name: BOTOX
Non Proprietary Name: onabotulinumtoxinA
Active Ingredient(s): 100    [USP'U]/1 & nbsp;   onabotulinumtoxinA
Administration Route(s): INTRADERMAL; INTRAMUSCULAR
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of BOTOX

Product NDC: 0023-1145
Labeler Name: Allergan, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103000
Marketing Category: BLA
Start Marketing Date: 19891215

Package Information of BOTOX

Package NDC: 0023-1145-02
Package Description: 1 VIAL in 1 CARTON (0023-1145-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

NDC Information of BOTOX

NDC Code 0023-1145-02
Proprietary Name BOTOX
Package Description 1 VIAL in 1 CARTON (0023-1145-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Product NDC 0023-1145
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name onabotulinumtoxinA
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRADERMAL; INTRAMUSCULAR
Start Marketing Date 19891215
Marketing Category Name BLA
Labeler Name Allergan, Inc.
Substance Name BOTULINUM TOXIN TYPE A
Strength Number 100
Strength Unit [USP'U]/1
Pharmaceutical Classes Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]

Complete Information of BOTOX


General Information